Recombinant human tissue kallikrein
DM199-2017-001
Phase 2 small_molecule completed
Quick answer
Recombinant human tissue kallikrein for Acute Ischemic Stroke is a Phase 2 program (small_molecule) at DiaMedica Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- DiaMedica Therapeutics
- Indication
- Acute Ischemic Stroke
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed